ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Walter Curran Succeeds Brian Leyland-Jones As Director Of Emory’s Cancer Center

September 25, 2009

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

NCI to Fund research In Tobacco Use Prevention In Youth

December 6, 1996

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010

NIH To Fund Fewer Grants This Year, But Reduce Cuts to Individual Awards.

February 8, 2008

Arizona Cancer Center Wins Core Grant Renewal

June 26, 2009